On the occasion of World Mental Health Day on 10 October, the Science Media Centre Spain organised an information session on the mental health of young people and the threat posed by deepfakes and cyberbullying. At the meeting, experts Esther Calvete and Irene de la Vega explained their risks and possible repercussions, their characteristics and some tools to reduce their frequency and impact.

On the occasion of World Cancer Research Day on 24 September, the Science Media Centre Spain organised an information session on mass screening. At the meeting, researchers Adrian Aginagalde, Isabel Portillo and Juan Carlos Trujillo explained how mass screening is studied, analysed its advantages and disadvantages, explained how its implementation is decided and what new developments we can expect.

When considering which type of timetable is best, one question is: best for what and for whom? Not only does the scientific evidence on student learning and well-being come into play, but also the employment interests of teachers, the reconciliation needs of families, and the effects of each type of timetable on socio-economic inequality and the gender gap in care are also involved. We bring together more elements of the discussion in this second article.

Every school year in Spain, the debate returns about what kind of timetable schools should adopt: is it better to concentrate all teaching hours or to have a lunch break and extend the time spent at school? In this first issue, we bring together research on the effect of each type of timetable on students' performance, rest and socio-affective well-being, as well as the available data on public and charter education.

Invasive species cause great damage to ecosystems, the economy and human health, but their impacts are underestimated. These are the main conclusions of a report published by the Intergovernmental Science-Policy Platform on Biological Diversity and Ecosystem Services (IPBES). Three researchers who participated in the document explained their results in an informative session organized by the Science Media Center Spain.

Heat waves and other events accentuated by climate change affect health, especially for the most socially vulnerable people. To counteract these effects, mitigation and adaptation plans for cities are designed based on scientific evidence, the implementation of which belongs to the local political sphere. Two experts in urban health and climate governance analysed these problems and their possible solutions in a briefing organised by SMC Spain.

The hydrological, meteorological and agricultural drought that is being experienced in Spain, especially in some regions, comes after a 2022 that was the warmest and one of the driest since records have been kept. Researchers Sandra García Galiano (UPCT) and Annelies Broekman (CREAF) participated in an informative session of SMC Spain in which they analyzed the causes, consequences and possible solutions to face this complex natural phenomenon.

Obesity is a growing public health problem for the entire planet. According to the 2023 Obesity Atlas published this week by the World Obesity Federation, 51% of the world's population will be overweight or obese (more than 4 billion people) by 2035, up from 38% today. At a briefing organised by SMC Spain ahead of World Obesity Day on 4 March, two experts discussed the role that drugs can play in combating a disease whose roots are social and linked to inequality. 

Outbreaks of highly pathogenic H5N1 avian influenza have been increasing since 2021, but in recent months have evolved into what is known as a 'global panzootic' affecting all types of wild birds and new continents, but also mammals such as mink and sea lions. At a briefing organised by SMC Germany, in collaboration with SMC UK and SMC Spain, three experts discussed the situation, the level of risk and possible next steps.

News of cancer vaccines proliferate in the media, yet only one such vaccine has been approved - against metastatic prostate cancer - and is no longer in use. However, only one as such has been approved - against metastatic prostate cancer - and it is no longer in use. Are the attention and hopes justified? What do they consist of and how are they similar to traditional ones? Are they preventive or therapeutic? Can they be universal or will they be extremely personalised? How much will they cost? This is what we know today.